Valirx【VAL】銘柄情報

Valirx Plc (VAL) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.185

( - )

買値

0.18

売値

0.19

出来高

1,380,599

0.185 日の範囲 0.185

0.18 52 週間の範囲 0.80

時価総額

1.42M

前日終値

0.185

始値

0.185

時刻

1230599

0.18

(O)

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

10,114,758p

発行済株式数

767,801,072

配当利回り

PER

-0.26

1 株当たり利益 (EPS)

-0.01

歳入

49.78k

純利益

-1.78M

ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company develops VAL201, a short peptide that has completed Phase I/II trials for the treatment of prostate cancer; and VAL401, a reformulation of anti-ps... ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company develops VAL201, a short peptide that has completed Phase I/II trials for the treatment of prostate cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of end-stage non-small cell lung cancer. It also develops VAL301, a peptide ingredient that in pre-clinical development for the treatment of endometriosis; BC201, a combination of the peptide ingredient of VAL201/VAL301 with complementary active components for the treatment for patients suffering severe symptoms of Covid-19; and CLX001, a peptide nanoparticle formulation that is in pre-clinical trial for destruction of cancer cells. The company also develops and commercializes oncology assets in the veterinary market. It has an agreement with University of Dundee. ValiRx plc was incorporated in 2000 and is based in London, the United Kingdom. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.valirx.com

本社

London, United Kingdom

設立

2026

Valirx Plc is listed in the Healthcare sector of the ロンドン証券取引所 with ticker VAL. The last closing price for Valirx was 0.19p. Over the last year, Valirx shares have traded in a share price range of 0.18p to 0.80p.

Valirx currently has 767,801,072 shares in issue. The market capitalisation of Valirx is £1.42 million. Valirx has a price to earnings ratio (PE ratio) of -0.26.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0.185	0.19	0.185	13556525	0.185	DE
4	-0.01	-5.12820512821	0.195	0.2	0.18	17213194	0.19147677	DE
12	-0.13	-41.2698412698	0.315	0.315	0.18	10185931	0.20740256	DE
26	-0.215	-53.75	0.4	0.47	0.18	8420341	0.27884336	DE
52	-0.29	-61.0526315789	0.475	0.8	0.18	8116022	0.33754149	DE
156	-8.065	-97.7575757576	8.25	14.75	0.18	4212881	0.95112117	DE
260	-20.815	-99.119047619	21	64	0.18	2961615	4.35923388	DE